{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:22:10Z","timestamp":1792214530810,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.tips.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T16:46:39Z","timestamp":1424450799000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["The 12\/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Yash B.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip F.","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2015.01.005_bib0290","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.abb.2010.08.016","article-title":"Molecular enzymology of lipoxygenases","volume":"503","author":"Ivanov","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tips.2015.01.005_bib0295","article-title":"Mammalian lipoxygenases and their biological relevance","author":"Kuhn","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2015.01.005_bib0300","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.2174\/092986712803530520","article-title":"Human lipoxygenase: developments in its structure, function, relevance to diseases and challenges in drug development","volume":"19","author":"Skrzypczak-Jankun","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tips.2015.01.005_bib0305","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.biotechadv.2012.04.004","article-title":"Lipoxygenases: potential starting biocatalysts for the synthesis of signaling compounds","volume":"30","author":"Joo","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.tips.2015.01.005_bib0310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0090-6980(02)00035-7","article-title":"Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications","volume":"68\u201369","author":"Kuhn","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tips.2015.01.005_bib0315","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/jmbi.1998.1737","article-title":"Simultaneous expression of leukocyte-type 12-lipoxygenase and reticulocyte-type 15-lipoxygenase in rabbits","volume":"278","author":"Berger","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2015.01.005_bib0320","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1432-1033.1993.tb17699.x","article-title":"Molecular cloning of a 12-lipoxygenase cDNA from rat brain","volume":"212","author":"Watanabe","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0325","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1471-4159.1992.tb11355.x","article-title":"Localization of arachidonate 12-lipoxygenase in canine brain tissue","volume":"58","author":"Nishiyama","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0330","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.ATV.0000133606.69732.4c","article-title":"Lipid inflammatory mediators in diabetic vascular disease","volume":"24","author":"Natarajan","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2015.01.005_bib0335","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstr\u00f6m","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tips.2015.01.005_bib0340","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2015.01.005_bib0345","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2015.01.005_bib0350","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2174\/15680266113139990141","article-title":"Clinical pharmacology of novel anti-Alzheimer disease modifying medications","volume":"13","author":"Caraci","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2015.01.005_bib0355","series-title":"Diet and Nutrition in Dementia and Cognitive Decline","first-page":"13","article-title":"Alzheimer's disease","author":"Giannopoulos","year":"2014"},{"key":"10.1016\/j.tips.2015.01.005_bib0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-4159.2011.07187.x","article-title":"Low-n oligomers as therapeutic targets of Alzheimer's disease","volume":"117","author":"Ono","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localization of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2015.01.005_bib0370","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-5793(93)80849-P","article-title":"Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5","volume":"336","author":"Baumann","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2015.01.005_bib0375","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen cynthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tips.2015.01.005_bib0380","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00109-012-0954-4","article-title":"12\/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance","volume":"90","author":"Uderhardt","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.tips.2015.01.005_bib0385","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1097-4652(199606)167:3<477::AID-JCP12>3.0.CO;2-1","article-title":"Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation","volume":"167","author":"Sultana","year":"1996","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.tips.2015.01.005_bib0390","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1074\/jbc.M111305200","volume":"277","author":"Reddy","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.01.005_bib0395","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.103.18.2277","article-title":"Absence of 12\/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice","volume":"103","author":"Cyrus","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2015.01.005_bib0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/db07-0830","article-title":"Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12\/15-lipoxygenase are protected from autoimmune diabetes","volume":"57","author":"McDuffie","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2015.01.005_bib0405","doi-asserted-by":"crossref","first-page":"e7250","DOI":"10.1371\/journal.pone.0007250","article-title":"12\/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice","volume":"4","author":"Sears","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2015.01.005_bib0410","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1074\/jbc.M303857200","article-title":"12\/15-Lipoxygenase activity mediates inflammatory monocyte\/endothelial interactions and atherosclerosis in vivo","volume":"279","author":"Reilly","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2015.01.005_bib0415","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-011-0412-7","article-title":"Lipoxygenases and poly(ADP-ribose) polymerase in amyloid beta cytotoxicity","volume":"36","author":"Strosznajder","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2015.01.005_bib0420","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/41.1.8417106","article-title":"Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain","volume":"41","author":"Nishiyama","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0425","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","article-title":"A role for 12-lipoxygenase in nerve cell death casued by glutathione depletion","volume":"19","author":"Li","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2015.01.005_bib0430","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)61224-2","article-title":"Absence of 12\/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice","volume":"167","author":"Chinnici","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2015.01.005_bib0435","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","article-title":"Oxidative stress hypothesis in Alzheimer's disease: a reappraisal","volume":"29","author":"Pratic\u00f2","year":"2008","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.tips.2015.01.005_bib0440","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)63724-8","article-title":"12\/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress","volume":"164","author":"Pratico","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2015.01.005_bib0445","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ana.20558","article-title":"Elevation of 12\/15 lipoxygenase products in AD and mild cognitive impairment","volume":"58","author":"Yao","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2015.01.005_bib0450","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tips.2015.01.005_bib0455","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1471-4159.2007.04742.x","article-title":"A role for 12\/15 lipoxygenase in the amyloid beta precursor protein metabolism","volume":"103","author":"Succol","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0575","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2010.04.010","article-title":"Amelioration of the Alzheimer's disease phenotype by absence of 12\/15-lipoxygenase","volume":"68","author":"Yang","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2015.01.005_bib0465","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ana.22625","article-title":"Transcriptional regulation of beta-secretase-1 by 12\/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments","volume":"71","author":"Chu","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2015.01.005_bib0470","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/acel.12136","article-title":"The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo","volume":"12","author":"Giannopoulos","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.tips.2015.01.005_bib0475","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2015.01.005_bib0460","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2014.170","article-title":"Pharmacologic blockade of 12\/15-Lipoxygenase ameliorates memory deficits, A\u03b2 and tau neuropathology in the triple transgenic mouse","author":"Chu","year":"2015","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.tips.2015.01.005_bib0580","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(96)00428-3","article-title":"Involvement of the 12-lipoxygenase pathway of arachidonic acid metabolism in homosynaptic long-term depression of the rat hippocampus","volume":"730","author":"Normandin","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2015.01.005_bib0490","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1523\/JNEUROSCI.23-36-11427.2003","article-title":"12-lipoxygenase metabolites of arachidonic acid mediate metabotropic glutamate receptor-dependent long-term depression at hippocampal CA3-CA1 synapses","volume":"23","author":"Feinmark","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2015.01.005_bib0495","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1523\/JNEUROSCI.2168-09.2010","article-title":"12-Lipoxygenase regulates hippocampal long-term potentiation by modulating L-type Ca2+ channels","volume":"30","author":"DeCostanzo","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2015.01.005_bib0500","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrn1106","article-title":"Mechanisms, challenges and opportunities in stroke","volume":"4","author":"Lo","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2015.01.005_bib0505","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/ars.2010.3573","article-title":"Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes","volume":"14","author":"Hardingham","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tips.2015.01.005_bib0510","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2015.01.005_bib0515","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-4159.2009.05897.x","article-title":"Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival","volume":"109","author":"Niizuma","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2015.01.005_bib0520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/MN:31:1-3:105","article-title":"Oxidative stress and neuronal death\/survival signaling in cerebral ischemia","volume":"31","author":"Saito","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2015.01.005_bib0525","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/156720505774330573","article-title":"The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death","volume":"2","author":"LeBlanc","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tips.2015.01.005_bib0530","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.cdd.4401395","article-title":"Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide","volume":"11","author":"Lebeau","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tips.2015.01.005_bib0540","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2015.01.005_bib0535","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.STR.20.7.925","article-title":"Effect of cyclooxygenase and lipoxygenase inhibitors on delayed neuronal death in the gerbil hippocampus","volume":"20","author":"Nakagomi","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2015.01.005_bib0545","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/STROKEAHA.108.514927","article-title":"Protecting against cerebrovascular injury: contributions of 12\/15-lipoxygenase to edema formation after transient focal ischemia","volume":"39","author":"Jin","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2015.01.005_bib0550","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/01.STR.0000249004.25444.a5","article-title":"Baicalein and 12\/15-lipoxygenase in the ischemic brain","volume":"37","author":"van Leyen","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.tips.2015.01.005_bib0555","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.23734","article-title":"Inhibition of 12\/15-lipoxygenase as therapeutic strategy to treat stroke","volume":"73","author":"Yigitkanli","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2015.01.005_bib0560","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2012.07.047","article-title":"Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation\/nitration, 12\/15-lipoxygenase and blood\u2013brain barrier disruption","volume":"1473","author":"Sun","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2015.01.005_bib0565","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/jcbfm.2009.281","article-title":"Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12\/15-lipoxygenase-dependent organelle damage pathway","volume":"30","author":"Pallast","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tips.2015.01.005_bib0570","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuroscience.2007.09.033","article-title":"Baicalein, an antioxidant 12\/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes","volume":"150","author":"Lapchak","year":"2010","journal-title":"Neuroscience"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614715000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T09:45:03Z","timestamp":1717753503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614715000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0165614715000152"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2015.01.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 12\/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}